American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
By H. Rodbard, L. Blonde, S. Braithwaite, Elise M. Brett, R. Cobin, Y. Handelsman, Richard Hellman, P. Jellinger, L. Jovanovič, P. Levy and 2 more. Endocrine Practice, 2007
788 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Pharmacology
View Paper: https://www.semanticscholar.org/paper/56c374d8b75030219e8da8e6aaec93ea976d81ff
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- Y. Ding
- Yoshimasa Tanaka
- Wen Zhang
- Yanling Wu
- Silvio E. Inzucchi
- I. Hirsch
- M. S. Kirkman
- G. Umpierrez
Citations in the corpus
- Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention (2014, background): “Metformin has been proven to be efficacious in lowering blood glucose, increasing insulin sensitivity, reducing cardiovascular [92] and hypoglycemia risk [93], and is the only hypoglycemic agent to improve macrovascular outcomes [94] and to reduce mortality rates in T2DM patients [95].”
- American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control (2009, background): “Accordingly, reasonable glucose targets in the hospital setting are modestly higher than may be routinely advised for patients with diabetes in the outpatient setting (85,86).”